Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Levitra is used to treat erectile dysfunction (impotence) and works by relaxing muscles and increasing blood flow in the body. It is classified as a PDE5 inhibitor and is co-manufactured by Bayer AG and GlaxoSmithKline.
Levitra and other drugs in its class have been associated to serious side effects. In 2005, the FDA issued a warning informing doctors and patients about non-arteritic anterior ischemic optic neuropathy (NAION) as a risk associated with PDE5 inhibitors.
NAION starts to affect Levitra users within 36 hours of taking the drug. This condition happens when vision loss occurs to damage to the optic nerve from a lack of blood supply. Patients suffering from NAION describe dark shadows or poor vision in one eye.
In addition to NAION risks, Levitra has also been linked to hearing loss in patients. In 2007, the FDA received reports of sudden hearing loss after taking in erectile dysfunction medications.
Serious side effects may include:
Less serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.